Medicine and Dentistry
Interferon
100%
Platelet
100%
Chronic Hepatitis C
100%
Transient Elastography
100%
Hepatocellular Carcinoma
66%
Liver Cirrhosis
66%
Fibrosis
66%
Alkaline Phosphatase
33%
Disease Exacerbation
33%
Liver Fibrosis
33%
Clinical Health
33%
Disease Activity
33%
Liver Biopsy
33%
Decompensated Liver Cirrhosis
33%
Nursing and Health Professions
Interferon
100%
Chronic Hepatitis C
100%
Platelet Count
100%
Transient Elastography
100%
Fibrosis
66%
Liver Cell Carcinoma
66%
Liver Cirrhosis
66%
National Health Organization
33%
Disease Exacerbation
33%
Disease Activity
33%
Liver Fibrosis
33%
Liver Biopsy
33%
Alkaline Phosphatase
33%
Decompensated Liver Cirrhosis
33%
Keyphrases
Chronic Hepatitis C
100%
Sustained Virological Response
100%
Interferon-based Therapy
100%
Platelet Count
37%
Transient Elastography
37%
Hepatocellular Carcinoma
25%
Cirrhosis
25%
Fibrosis
25%
National Institutes of Health
12%
Low Risk
12%
Serum Markers
12%
Disease Progression
12%
Clinical Centers
12%
Ratio Index
12%
Disease Activity
12%
Count Rate
12%
Hepatic Fibrosis
12%
Alkaline Phosphatase
12%
Liver Biopsy
12%
Long-term Consequences
12%
Hepatic Decompensation
12%
Treatment Value
12%
Short-term Benefits
12%
Pharmacology, Toxicology and Pharmaceutical Science
Interferon
100%
Chronic Hepatitis C
100%
Liver Cell Carcinoma
66%
Fibrosis
66%
Liver Cirrhosis
66%
Disease Exacerbation
33%
Disease Activity
33%
Liver Fibrosis
33%
Alkaline Phosphatase
33%
Decompensated Liver Cirrhosis
33%
Immunology and Microbiology
Hepatitis C
100%
interferon
100%
Platelet Count
100%